although p-gp may be not the unique mechanism responsible for resistance towards plicamycin and hydroxyurea association , the mdr phenotype may play an important role in the resistance towards this treatment protocol in the blast crisis of chronic myeloid leukemia .
C0026234
plicamycin
C0023473
chronic myeloid leukemia